Sisheng Technology

Based in Beijing, China, and founded in 2025, Beijing Sisheng Technology Co. , Ltd. , trading as Sisheng Technology, engages in ultrasound brain-computer interface hardware development, clinical application of medical devices, and the construction of AI brain science platforms. In June 2026, Sisheng Technology raised a Seed funding from Innoangel Fund and Lighthouse Capital Group.

Its products simultaneously achieve systematic capabilities in four dimensions: reading brain activity signals, precisely controlling target brain regions, decoding and decision-making through AI models, and forming closed-loop feedback. The company generates revenue by developing and commercializing ultrasound brain‑computer interface (BCI) hardware and related medical devices. The Seed funding raised in June 2026 will be primarily used for core technology R&D, the advancement of first-generation medical device products, the construction of an AI brain science platform, and the recruitment of key talent.